BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15815722)

  • 1. Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays.
    Mestre C; Rubio-Moscardo F; Rosenwald A; Climent J; Dyer MJ; Staudt L; Pinkel D; Siebert R; Martinez-Climent JA
    Leukemia; 2005 Jun; 19(6):1082-4. PubMed ID: 15815722
    [No Abstract]   [Full Text] [Related]  

  • 2. Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein.
    Melzner I; Weniger MA; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Leithäuser F; Ritz O; Dyer MJ; Barth TF; Möller P
    Int J Cancer; 2006 Apr; 118(8):1941-4. PubMed ID: 16287070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.
    Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
    Blood; 2005 Mar; 105(6):2535-42. PubMed ID: 15572583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How frequent is SOCS1 methylation in acute myeloid leukaemia?
    Chim CS; Kwong YL
    Br J Haematol; 2004 Dec; 127(5):609-11. PubMed ID: 15566368
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line].
    Barth TF; Melzner I; Wegener S; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Leithäuser F; Möller P
    Verh Dtsch Ges Pathol; 2005; 89():234-44. PubMed ID: 18035697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
    Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM
    J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).
    Wessendorf S; Barth TF; Viardot A; Mueller A; Kestler HA; Kohlhammer H; Lichter P; Bentz M; Döhner H; Möller P; Schwaenen C
    Leukemia; 2007 Dec; 21(12):2463-9. PubMed ID: 17728785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway.
    Chim CS; Wong KY; Loong F; Srivastava G
    Leukemia; 2004 Feb; 18(2):356-8. PubMed ID: 14614518
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.
    Ben-Zvi T; Yayon A; Gertler A; Monsonego-Ornan E
    J Cell Sci; 2006 Jan; 119(Pt 2):380-7. PubMed ID: 16410555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prospective on molecular diagnostics of primary mediastinal B-cell lymphoma and its clinical implications].
    Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):77-81. PubMed ID: 34979764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of SOCS-1 gene methylation in acute myeloid leukaemia.
    Watanabe D; Naka T; Kishimoto T
    Br J Haematol; 2004 Dec; 127(5):608-9. PubMed ID: 15566367
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.
    Mottok A; Renné C; Seifert M; Oppermann E; Bechstein W; Hansmann ML; Küppers R; Bräuninger A
    Blood; 2009 Nov; 114(20):4503-6. PubMed ID: 19734449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation.
    Davey GM; Heath WR; Starr R
    Tissue Antigens; 2006 Jan; 67(1):1-9. PubMed ID: 16451196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis.
    Yoshida T; Ogata H; Kamio M; Joo A; Shiraishi H; Tokunaga Y; Sata M; Nagai H; Yoshimura A
    J Exp Med; 2004 Jun; 199(12):1701-7. PubMed ID: 15197228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
    Dai H; Ehrentraut S; Nagel S; Eberth S; Pommerenke C; Dirks WG; Geffers R; Kalavalapalli S; Kaufmann M; Meyer C; Faehnrich S; Chen S; Drexler HG; MacLeod RA
    PLoS One; 2015; 10(11):e0139663. PubMed ID: 26599546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes.
    Dai X; Sayama K; Yamasaki K; Tohyama M; Shirakata Y; Hanakawa Y; Tokumaru S; Yahata Y; Yang L; Yoshimura A; Hashimoto K
    J Invest Dermatol; 2006 Jul; 126(7):1574-81. PubMed ID: 16628196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma.
    Melzner I; Weniger MA; Menz CK; Möller P
    Leukemia; 2006 Jan; 20(1):157-8. PubMed ID: 16331280
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 1, a newly proposed tumor suppressor gene associated with hepatocellular carcinoma.
    Ohkawa K
    J Gastroenterol; 2004 Jun; 39(6):598-600. PubMed ID: 15235884
    [No Abstract]   [Full Text] [Related]  

  • 19. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.
    Weniger MA; Pulford K; Gesk S; Ehrlich S; Banham AH; Lyne L; Martin-Subero JI; Siebert R; Dyer MJ; Möller P; Barth TF
    Leukemia; 2006 Oct; 20(10):1880-2. PubMed ID: 16871282
    [No Abstract]   [Full Text] [Related]  

  • 20. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
    Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
    Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.